Keyphrases
Breast Cancer Cells
100%
Cyclin-dependent Kinase 4 (CDK4)
100%
Endocrine Therapy
100%
Antiestrogen
100%
WEE1
100%
Estrogen Receptor-positive
75%
Resistant Cells
75%
G2 Checkpoint
75%
Tumor
50%
Cell Proliferation
25%
Estrogen
25%
Breast Tumor
25%
DNA Repair
25%
Cell Death
25%
Therapy-resistant
25%
Apoptosis
25%
DNA Double-strand Breaks
25%
Estrogen Receptor-positive Breast Cancer
25%
Adavosertib
25%
G1 Phase
25%
Tumor Resistance
25%
Anticancer Therapeutics
25%
T47D Breast Cancer Cells
25%
Intrinsic Resistance
25%
G1 Checkpoint
25%
G2-M Arrest
25%
MCF7 Breast Cancer Cells
25%
Endocrine Resistance
25%
γH2AX
25%
Cancer Therapeutic Strategy
25%
AZD1775
25%
Overall Survival of Patients
25%
Medicine and Dentistry
Breast Cancer
100%
Cancer Cell
100%
Antiestrogen
100%
Hormone Therapy
100%
CDK4/6 Inhibitor
100%
G2 Phase Cell Cycle Checkpoint
75%
Estrogen Receptor
75%
Tumor
50%
Adavosertib
50%
Malignant Neoplasm
25%
Breast Tumor
25%
Cell Cycle
25%
Programmed Cell Death
25%
Cell Proliferation
25%
DNA Repair
25%
Overall Survival
25%
G1/S Transition
25%
G1 Phase
25%
Estrogen Receptor Positive Breast Cancer
25%
Tumor Resistance
25%
Cell Death
25%
Double-Strand DNA Break
25%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Breast Cancer
100%
Antiestrogen
100%
Estrogen Receptor
75%
Adavosertib
50%
Intrinsic Resistance
25%
Malignant Neoplasm
25%
Breast Tumor
25%
Estrogen Receptor Positive Breast Cancer
25%
Overall Survival
25%
Double Stranded DNA
25%
Tumor Resistance
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Estrogen Receptor
100%
G2 Phase Cell Cycle Checkpoint
75%
Anticancer
25%
DNA Repair
25%
Overall Survival
25%
Cell Cycle
25%
Cell Proliferation
25%
G1 Phase
25%
G1/S Transition
25%
Cell Death
25%
Programmed Cell Death
25%
Double-Strand DNA Break
25%